Nervonik, Inc., a medical technology company developing a next-generation peripheral nerve stimulation platform for chronic pain, today announced it is expanding its leadership team with the addition of several experienced medical device and neuromodulation leaders - Rob DiTota, Dan Brounstein, and Patrick Martin - as the company moves toward its planned 510(k) submission and commercial launch.